[Psychedelic-assisted psychotherapy in palliative medicine].
Amandine Schaller, Géraldine Bourquin, Indira Amorim Araujo, Michael Ljuslin
Revue medicale suisse December 20, 2023 DOI: 10.53738/REVMED.2023.19.855.2395 via PubMed
Summary
AI-generated from the abstractPsychedelic-assisted psychotherapy (PAP) combines preparation, substance intake, and integration of experiences to facilitate profound psychospiritual change. Despite methodological and administrative hurdles, interest in this innovative approach continues to grow because of its potential to offer remission where conventional approaches have shown little benefits.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Population | Palliative care patients with depression, anxiety, and existential distress |
| Intervention | Psychedelic-assisted psychotherapy |
| Key finding | Psychedelic-assisted psychotherapy may offer remission for depression, anxiety, and existential distress in palliative care patients where conventional treatments have shown little benefit. |
Abstract
Depression, anxiety and existential distress associated with terminal illness have a major impact on quality of life among palliative care patients. Psychedelics are emerging as catalysts for reflective, introspective and sometimes spiritual exploration as part of psychotherapy, with potentially rapid and long-lasting multiple beneficial effects. Psychedelic-assisted psychotherapy (PAP) combines preparation, substance intake, and integration of experiences to facilitate profound psychospiritual change. Despite methodological and administrative hurdles, interest in this innovative approach continues to grow because of its potential to offer remission where conventional approaches have shown little benefits.